DK0650736T3 - Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin - Google Patents

Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin

Info

Publication number
DK0650736T3
DK0650736T3 DK94116937T DK94116937T DK0650736T3 DK 0650736 T3 DK0650736 T3 DK 0650736T3 DK 94116937 T DK94116937 T DK 94116937T DK 94116937 T DK94116937 T DK 94116937T DK 0650736 T3 DK0650736 T3 DK 0650736T3
Authority
DK
Denmark
Prior art keywords
sterilizing
serum albumin
human serum
pharmaceutical preparation
recombinant human
Prior art date
Application number
DK94116937T
Other languages
Danish (da)
English (en)
Inventor
Tomoshi Ohya
Shinobu Kuwae
Kenji Tomomitsu
Kaoru Kobayashi
Takao Ohmura
Toyoo Ohda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17468634&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0650736(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of DK0650736T3 publication Critical patent/DK0650736T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94116937T 1993-10-27 1994-10-26 Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin DK0650736T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5269168A JPH07126182A (ja) 1993-10-27 1993-10-27 組換えヒト血清アルブミン製剤の滅菌方法

Publications (1)

Publication Number Publication Date
DK0650736T3 true DK0650736T3 (da) 2000-08-28

Family

ID=17468634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94116937T DK0650736T3 (da) 1993-10-27 1994-10-26 Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin

Country Status (8)

Country Link
US (1) US5691451A (fr)
EP (1) EP0650736B1 (fr)
JP (1) JPH07126182A (fr)
KR (1) KR100371045B1 (fr)
CA (1) CA2134535C (fr)
DE (1) DE69425033T2 (fr)
DK (1) DK0650736T3 (fr)
ES (1) ES2149230T3 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770676A3 (fr) * 1995-10-23 1999-05-19 Ajinomoto Co., Ltd. Méthode de traitement de bouillons de culture
DE69929022T2 (de) 1998-10-21 2006-07-13 Nipro Corp. Verfahren zur Herstellung eines Kunststoffbehälters für eine Albuminzubereitung
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
US6493867B1 (en) 2000-08-08 2002-12-10 Ball Semiconductor, Inc. Digital photolithography system for making smooth diagonal components
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
AU2004228847B2 (en) 2003-04-09 2010-06-17 Km Biologics Co., Ltd. Process for producing albumin preparation
JP4644604B2 (ja) 2004-01-20 2011-03-02 一般財団法人化学及血清療法研究所 ２価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
EP2471557A1 (fr) * 2010-12-27 2012-07-04 Università degli Studi di Genova Conjugué de l'albumine humaine et de l' acide 2-(4-isothiocyanatobenzyl)-1,4,7,10-tétraazacyclododécane-1,4,7,10-tétraacétique pour la localisation de radionucléides à des fins diagnostiques et thérapeutiques
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
WO2016108211A1 (fr) 2015-01-01 2016-07-07 Navya Biologicals Pvt Ltd Nouveau procédé de purification efficace de sérumalbumine humaine
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
EP4267210A1 (fr) 2020-12-28 2023-11-01 Davol Inc. Matériaux hémostatiques pulvérulents secs réactifs comprenant une protéine et un agent de réticulation à base de polyéthylène glycol modifié multifonctionnalisé

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法

Also Published As

Publication number Publication date
EP0650736B1 (fr) 2000-06-28
EP0650736A1 (fr) 1995-05-03
DE69425033D1 (de) 2000-08-03
KR950010898A (ko) 1995-05-15
CA2134535A1 (fr) 1995-04-28
CA2134535C (fr) 2004-06-08
JPH07126182A (ja) 1995-05-16
US5691451A (en) 1997-11-25
KR100371045B1 (ko) 2003-03-19
DE69425033T2 (de) 2001-03-08
ES2149230T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
DK0570916T3 (da) Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK0650736T3 (da) Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin
DK0699687T3 (da) Fremgangsmåde til oprensning af rekombinant humant serumalbumin
FI20030210L (fi) Suun kautta annettavat farmaseuttiset valmisteet sekä menetelmä niiden valmistamiseksi
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
NO922005D0 (no) Farmasoeytiske preparater
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
FI961037A7 (fi) Valmisteet osteogenisten proteiinien antamiseksi
FI952932L (fi) Monomeeriset insuliinianalogivalmisteet
ATE221374T1 (de) Lyophilisierte stabile pharmazeutische formulierung
NO943888D0 (no) Farmasöytisk preparat
DK184890D0 (da) Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme
DK148092D0 (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til selektiv nedsaettelse af lipidniveauet i blodet
FI961521L (fi) Lääkeformulaatioiden valmistusmenetelmä
DK28795A (da) Insulinholdigt polymerpræparat til oral administrering af insulin
DK0656419T3 (da) Fremgangsmåde til højrensning af humant serumalbumin
FI913100A7 (fi) Farmaseuttiset valmisteet
DK0504823T3 (da) Fremgangsmåde til fremstilling af human serumalbumin
DK0591605T3 (da) Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
DK0655503T3 (da) Fremgangsmåde til fremstilling af humant serumalbumin
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK0658569T3 (da) Fremgangsmåde til affarvning af humant serumalbumin
DK13087A (da) Gensekvens til fremstilling af human serumalbumin i bacillus
DK244489D0 (da) Fremgangsmaade til terapeutisk administration af laegemidlet l-deprenyl